An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Investigational Drug Acquiring Traction Online
The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are encouraged to message these accounts directly for source information, while also receiving discount codes.
Active Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with numerous of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Experts Express Worries
However, physicians and chemists have warned that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.
Several professionals said the demand for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.
Several content creators try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, marketing, and consumer laws, risking penalties, prosecution or prison.
Platform Response and Content Removal
According to the social media company, the service has removed violative material and prohibited associated keywords and query recommendations. The company stated it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.
Digital Trading Activities
Investigations also discovered communities with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with numerous of members, filled with photos of slimming results, positive reviews and step-by-step instructions for preparing or administering at home.
After minutes of entering one group, a seller shared contact information, where most transactions occur. The seller provided an guidebook and promised delivery within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about body mass, health issues or past usage.
Item Details and Costs
Inside these communities, posts display black plastic parcels with postal service labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A representative for the messaging service stated it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering substances they cannot confirm. Even if the science behind this drug is sound, these online versions may not include what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are using social media. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.
Her team has previously encountered individuals injured by self-injection from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may expose users to potentially significant health risks”.
